60 studies found for:    physical | urticaria
Show Display Options
Rank Status Study
21 Completed Phase II Solar Urticaria (SU) Pilot Study
Condition: Solar Urticaria
Intervention: Drug: afamelanotide
22 Recruiting Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID / CAPS, DIRA, CANDLE, SAVI, CRMO, Still's Disease, Behcet's Disease, and Other Undifferentiated Autoinflammatory Diseases)
Conditions: Urticaria;   Arthropathy;   Lymphadenopathy;   Nervous System Anomalies
23 Not yet recruiting Efficacy and Safety of Omalizumab in Patients With Severe Acute Urticaria
Condition: Urticaria
Intervention: Drug: omalizumab
24 Recruiting Cold Contact Urticaria Treatment With Rilonacept
Condition: Cold Contact Urticaria
Interventions: Drug: Rilonacept;   Drug: Placebo
25 Recruiting Bilastine Updosing in Chronic Spontaneous Urticaria
Condition: Chronic Urticaria
Interventions: Drug: Bilastine;   Drug: Bilastin
26 Completed
Has Results
Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment
Condition: Chronic Idiopathic Urticaria
Interventions: Drug: IGE025;   Drug: placebo
27 Completed Ilaris® in Urticarial Vasculitis - Investigation of Treatment Responses
Conditions: Urticaria;   Vasculitis
Intervention: Drug: canakinumab
28 Terminated Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions
Conditions: Atopic Dermatitis;   Psoriasis;   Alopecia;   Mycosis Fungoides;   Urticaria;   Dermatoses;   Stretch Marks
Interventions: Procedure: UVA1  Irradiation;   Procedure: UVB Irradiation
29 Completed Study on Mastocytosis for Rupatadine Treatment
Condition: Mastocytosis
Intervention: Drug: Rupatadin
30 Completed Bilastine Updosing - Characterization of Underlying Mechanisms
Condition: Cold Contact Urticaria
Intervention: Drug: Bilastine
31 Completed A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)
Conditions: Urticaria;   Chronic Idiopathic Urticaria
Intervention: Drug: desloratadine
32 Terminated Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
Conditions: Nervous System Malformations;   Arthropathy, Neurogenic;   Urticaria;   Papilledema
33 Completed Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With Urticaria
Condition: Urticaria
Intervention: Drug: Alesion®
34 Not yet recruiting Hereditary AngioEdema, Neurobiology and Psychopathology
Conditions: Hereditary AngioEdema;   Anxiety;   Depression
Intervention: Other: Clinical and psychopathological assessment of HAE patients
35 Recruiting Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
Conditions: Allergic Cutaneous Vasculitis;   Urticaria;   Psoriasis;   Acne;   Bullous Skin Diseases;   Sterile Pustulosis;   Leprosy;   Pneumocystis Pneumonia
Intervention: Drug: Dapsone
36 Recruiting Study of Factors Regulating Mast Cell Proliferation
Condition: Mastocytosis
37 Completed Cause and Natural Course of Pediatric-Onset Mastocytosis
Condition: Mastocytosis
38 Not yet recruiting Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (advSM) and Relapsed or Refractory Myeloid Malignancies
Conditions: Aggressive Systemic Mastocytosis;   Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease;   Mast Cell Leukemia;   Relapsed or Refractory Myeloid Malignancies
Intervention: Drug: BLU-285
39 Recruiting First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BCX7353 in Healthy Volunteers
Condition: Hereditary Angioedema
Interventions: Drug: BCX7353;   Drug: Placebo to match BCX7353
40 Completed Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing
Conditions: Mastocytosis;   Anaphylaxis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years